![Menzo Havenga](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Menzo Havenga
Chief Executive Officer at Batavia Biosciences BV
Network origin in Menzo Havenga first degree
Entity | Entity type | Industry | |
---|---|---|---|
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.
13
| Extinct | Pharmaceuticals: Major | 13 |
Batavia Biosciences BV
![]() Batavia Biosciences BV Pharmaceuticals: MajorHealth Technology Batavia Biosciences BV provides biopharmaceutical process development services. It offers biopharmaceutical materials research and pre-clinical study services for biopharmaceutical clients. The firm services cover candidate selection, production of research materials, upstream and downstream process development, assay development, product characterization and clinical manufacturing and release. The company was founded in 2010 and is headquartered in Leiden, the Netherlands.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Introgene BV
2
| Extinct | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Menzo Havenga via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
ROYAL KPN N.V. | Major Telecommunications | Corporate Officer/Principal | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Holland Casino NV
![]() Holland Casino NV Media ConglomeratesConsumer Services Holland Casino BV operates and manages casino. It provides gambling activities in Holland. The firm also has casinos in Amsterdam, Breda, Eindhoven, Enschede, Groningen, Nijmegen, Rotterdam, Scheveningen, Schiphol Airport, Utrecht, Valkenburg and Venlo. The company was founded in 1975 and is headquartered in Hoofddorp, the Netherlands. | Media Conglomerates | Corporate Officer/Principal | |
Nyenrode Business Universiteit | College/University | Director/Board Member | |
TUNGSTEN CO. | Information Technology Services | Chairman | |
Achmea BV
![]() Achmea BV Multi-Line InsuranceFinance Achmea BV operates as a co-operative insurance company. It offers health, life, and non-life insurance services. The firm operates through the InterAmerican, Union, Eureko, Achmea Australia, and Onlia brands. The company was founded in 1811 and is headquartered in Zeist, Netherlands. | Multi-Line Insurance | Chief Executive Officer | |
ROYAL BOSKALIS WESTMINSTER N.V. | Engineering & Construction | Director of Finance/CFO | |
Stichting Pensioenfonds Unilever Nederland Progress
![]() Stichting Pensioenfonds Unilever Nederland Progress Investment ManagersFinance Stichting Pensioenfonds Unilever Nederland Progress (SPUNP) is a pension scheme management firm located in Rotterdam, Netherlands. SPUNP was established in 1921 and is a subsidiary of Unilever NV (XA: UNA). The firm manages the Unilever Group Pension Fund for Dutch employers. Progress is the foundation of the company pension schemes of Unilever, which invests in Dutch real estate. | Investment Managers | Director/Board Member | |
The University of Liverpool
![]() The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Doctorate Degree | |
Galapagos Biotech Ltd.
![]() Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Mogen International Nv
![]() Mogen International Nv Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Mogen International Nv is a Dutch company that specializes in medicinal chemicals and botanical products. The company is based in Leiden, the Netherlands. Mogen International was acquired by Zeneca Group Plc on May 01, 1997 for $74.96 million. | Pharmaceuticals: Other | Corporate Officer/Principal Corporate Officer/Principal | |
Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk
![]() Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Miscellaneous Commercial ServicesCommercial Services Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk provides scientific services. It includes research and consultancy for government, businesses and organizations. The company was founded in 1932 and is headquartered in Delft, Netherlands. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Amsterdam | College/University | Corporate Officer/Principal Doctorate Degree | |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
Stichting Beheer SNS REAAL | Investment Managers | Director/Board Member | |
Janssen Vaccines & Prevention BV
![]() Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
University of Leiden | College/University | Doctorate Degree | |
University of Utrecht | College/University | Corporate Officer/Principal Doctorate Degree | |
Vrije Universiteit Amsterdam | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
Polpharma Biologics Utrecht BV
![]() Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | Miscellaneous Commercial Services | Director/Board Member | |
ORCA Therapeutics BV
![]() ORCA Therapeutics BV Pharmaceuticals: GenericHealth Technology ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
MERUS N.V. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh
![]() Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenh Investment Trusts/Mutual FundsMiscellaneous Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek is a scientific research institute and a specialist clinic. The firm’s areas of research are including fundamental, clinical and translational cancer research. The company was founded in 1916 and is headquartered in Amsterdam, Netherlands. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
ProFibrix BV
![]() ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Adenovirus Research Group | Director/Board Member | ||
Stichting Onderzoek Cancer Center Amsterdam | Investment Trusts/Mutual Funds | Director/Board Member | |
Janssen Biologics BV
![]() Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Philips Electronics Nederland BV
![]() Philips Electronics Nederland BV Real Estate DevelopmentFinance Part of Koninklijke Philips NV, Philips Electronics Nederland BV owns, operates and leases nonresidential buildings. The company is based in Eindhoven, Netherlands. | Real Estate Development | Corporate Officer/Principal | |
DCPrime BV
![]() DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Executive Officer Director/Board Member | |
Molecular Probes Europe BV | Corporate Officer/Principal | ||
Rijksinstituut Voor Volksgezondheid En Milieu | Corporate Officer/Principal | ||
The Netherlands Biotech Industry Association | Director/Board Member | ||
Gist-Brocades NV | Corporate Officer/Principal | ||
Bioceros Holding BV
![]() Bioceros Holding BV Miscellaneous Commercial ServicesCommercial Services Bioceros Holding BV develops monoclonal antibodies and generating GMP-ready cell lines. engages in building therapeutic monoclonal antibodies, including targets in oncology and auto-immune diseases. It generates various cell lines that produce proteins ranging from blood proteins and monoclonal antibodies to fusion proteins. The company is headquartered in Utrecht, the Netherlands. | Miscellaneous Commercial Services | Chief Executive Officer | |
Gadeta BV
![]() Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Chief Executive Officer | |
Institute For Human Organ & Disease Model Technologies | Director/Board Member | ||
Hubrecht Organoid Technology Foundation | Director/Board Member Chief Executive Officer | ||
Leyden Laboratories B.V.
![]() Leyden Laboratories B.V. Miscellaneous Commercial ServicesCommercial Services Leyden Laboratories B.V. is a biotechnology company based in Amsterdam, Netherlands. Leyden Labs aims to protect humanity from known and future viruses by targeting commonalities of viral families. The Dutch company has developed a portfolio of accessible intranasal product candidates that may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The company's energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses. Leyden Labs is backed with $200m by blue-chip investors Casdin Capital, GV (formerly Google Ventures), F-Prime Capital, Byers Capital/Brook Byers, SoftBank Investment Advisers, Invus, and Bluebird Ventures. The company was founded in June 2020 by Koenraad Wiedhaup, Jaap Goudsmit, Domenico Valerio, and Ronald H. P. Brus, with Koenraad Wiedhaup serving as the CEO since incorporation. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Pensioenfonds Zorg en Welzijn | Investment Managers | Director/Board Member | |
KPN BV
![]() KPN BV Major TelecommunicationsCommunications KPN BV provides telecommunications and information technology services. It offers fixed and mobile telephony, fixed and mobile broadband internet and TV to retail consumers. The firm also offers infrastructure and network related ICT solutions to business customers, including other telecommunications operators. The company also provides wholesale network services to third parties and operates an IP-based infrastructure for international wholesale customers through KPN’s US-based subsidiary iBasis. The firm’s other brands include KPN, Telfort, XS4ALL, Simyo, Yes Telecom and Ortel Mobile. The company was founded in 1989 and is headquartered in The Hague, the Netherlands. | Major Telecommunications | Comptroller/Controller/Auditor |
Statistics
International
Netherlands | 38 |
United States | 7 |
United Kingdom | 4 |
Denmark | 2 |
Belgium | 2 |
Sectoral
Health Technology | 17 |
Consumer Services | 8 |
Finance | 8 |
Commercial Services | 5 |
Communications | 3 |
Operational
Corporate Officer/Principal | 45 |
Director/Board Member | 35 |
Chief Tech/Sci/R&D Officer | 14 |
Chief Executive Officer | 13 |
Chairman | 12 |
Most connected contacts
- Stock Market
- Insiders
- Menzo Havenga
- Company connections